Antiviral effects of recombinant tumour necrosis factor in vitro.
about
The C-mer gene is induced by Epstein-Barr virus immediate-early protein BRLF1Blockade of virus infection by human CD4+ T cells via a cytokine relay networkInhibition of Intrahepatic Gamma Interferon Production by Hepatitis C Virus Nonstructural Protein 5A in Transgenic MiceTumour necrosis factor production in fulminant hepatic failure: relation to aetiology and superimposed microbial infectionMicrobubble-mediated ultrasound promotes accumulation of bone marrow mesenchymal stem cell to the prostate for treating chronic bacterial prostatitis in ratsMechanisms in prostatitis/chronic pelvic pain syndrome.Posttranscriptional clearance of hepatitis B virus RNA by cytotoxic T lymphocyte-activated hepatocytesCoordinate viral induction of tumor necrosis factor alpha and interferon beta in human B cells and monocytesCytokines and their receptors in cardiovascular diseases--role of gp130 signalling pathway in cardiac myocyte growth and maintenance.Anti-Fas monoclonal antibody is cytocidal to human immunodeficiency virus-infected cells without augmenting viral replication.Overexpression of tumor necrosis factor alpha by a recombinant rabies virus attenuates replication in neurons and prevents lethal infection in miceInduction of the transcription factor IRF-1 and interferon-beta mRNAs by cytokines and activators of second-messenger pathwaysDisturbance of tumor necrosis factor alpha-mediated beta interferon signaling in cervical carcinoma cells.Tumor necrosis factor type alpha, a potent inhibitor of endothelial cell growth in vitro, is angiogenic in vivo.Tumor necrosis factor amplifies measles virus-mediated Ia induction on astrocytes.Epstein-Barr virus immediate-early protein BZLF1 inhibits tumor necrosis factor alpha-induced signaling and apoptosis by downregulating tumor necrosis factor receptor 1Secretory products of macrophages.The ELISPOT assay: an easily transferable method for measuring cellular responses and identifying T cell epitopes.Receptor-ligand requirements for increased NK cell polyfunctional potential in slow progressors infected with HIV-1 coexpressing KIR3DL1*h/*y and HLA-B*57Strong human endogenous retrovirus-specific T cell responses are associated with control of HIV-1 in chronic infection.Inhibition of growth of Chlamydia trachomatis by tumor necrosis factor is accompanied by increased prostaglandin synthesisProduction of tumor necrosis factors alpha and beta by human mononuclear leukocytes stimulated with mitogens, bacteria, and malarial parasitesHerpes simplex virus infection and apoptosis.Induction of susceptibility to tumor necrosis factor by E1A is dependent on binding to either p300 or p105-Rb and induction of DNA synthesisInflammatory infiltration of the trigeminal ganglion after herpes simplex virus type 1 corneal infectionAnti-human cytomegalovirus activity of cytokines produced by CD4+ T-cell clones specifically activated by IE1 peptides in vitro.Tumor necrosis factor alpha inhibits entry of human immunodeficiency virus type 1 into primary human macrophages: a selective role for the 75-kilodalton receptor.Herpes simplex virus type 2 inhibition of Fas ligand expression.The RNA binding domain of influenza A virus NS1 protein affects secretion of tumor necrosis factor alpha, interleukin-6, and interferon in primary murine tracheal epithelial cellsDeath effector domain-containing herpesvirus and poxvirus proteins inhibit both Fas- and TNFR1-induced apoptosisConvergent Transcription of Interferon-stimulated Genes by TNF-α and IFN-α Augments Antiviral Activity against HCV and HEV.Tumour necrosis factor in man: clinical and biological observations.Interferon beta 1, an intermediate in the tumor necrosis factor alpha-induced increased MHC class I expression and an autocrine regulator of the constitutive MHC class I expression.Three distinct classes of regulatory cytokines control endothelial cell MHC antigen expression. Interactions with immune gamma interferon differentiate the effects of tumor necrosis factor and lymphotoxin from those of leukocyte alpha and fibroblastTumor necrosis factor plays a protective role in experimental murine cutaneous leishmaniasis.Antiviral activity of tumor necrosis factor (TNF) is mediated via p55 and p75 TNF receptors.The molecular action of tumor necrosis factor-alpha.Repression of retrovirus-mediated transgene expression by interferons: implications for gene therapyThe adenovirus E3 14.7-kilodalton protein which inhibits cytolysis by tumor necrosis factor increases the virulence of vaccinia virus in a murine pneumonia model.Production of lipopolysaccharide-induced tumour necrosis factor during influenza virus infection in mice coincides with viral replication and respiratory oxidative burst.
P2860
Q24563120-FCDA9633-E99B-4395-BCC2-2BD587C13495Q27486090-29240416-D491-4096-9681-F1B188D7031AQ27489517-C57A0E95-C875-477A-A280-44A1B8E69A1BQ28329734-9303D296-C7EF-4E0E-B56F-0FFE93239229Q30392930-D3846E7C-D0CA-425D-920B-FBB01B7AF359Q33205985-BEB49FB5-D8ED-4710-96E9-DC19738598D2Q33677323-7DBA5FFD-E2CF-4405-948B-4854D6A117A6Q33839633-751FE9B8-5AAA-4702-A1C0-FBC98DC5ACF5Q33863961-3C31265A-2809-4A98-A39C-14C91394599FQ33923680-4A639245-E9E9-48E6-AE88-C8D772D69E0FQ34228539-FC17AFE0-1FDC-4C5A-A2EE-71B6F8307F7CQ34325874-281E1B3D-400E-4E59-8FFC-615924A577C9Q34326864-E3253086-09BD-432C-B7C6-97DD559A04DBQ34333796-8052BF64-2D51-4722-B8A5-639A11159619Q34354649-35858E74-10E1-4177-950E-E41FB4B038BBQ34553626-FBBF8392-9C7D-4C84-ABA2-7B0F9EAE0C78Q34557411-ECA54CBB-F16E-491B-B25D-8DA9F5EDD7A1Q34999197-9C9D707F-A1F8-46CE-876F-1A9C4DA82E93Q35077002-62107F8A-0ED8-479C-A9A7-C026F75F6915Q35077813-19546FC7-E19E-4932-96BE-C45D1B1F322DQ35105367-2967B571-32FC-4D62-8F8F-AA584AD96D22Q35109154-7DCDF7F6-86DD-4A96-B6CE-5636E853679BQ35613809-8774F048-798C-4735-B05C-9AE32F3BD474Q35853222-CDB0056E-E00E-4894-8B62-0591B4EDFD88Q35853529-A2855425-D4EF-4F24-9BA8-B3C97ED47615Q35858429-92CC50E3-06E5-47FB-814E-9DE2D664347DQ35871524-204B485B-A9A2-4550-8808-DBFC978EA2AFQ35873842-02D8B39D-29E7-4337-A049-6D9D9A2D2D02Q35947867-5D7BC11A-C043-4B9E-A05C-80E7B91949CBQ35990527-09E6C5E3-095A-43A9-BDE1-A0EA18A21D9CQ36009894-4CC0D13B-1EFB-4694-8C84-59D9E1B02066Q36029538-8C018229-B250-4C27-BAD4-BC6BF92C5B14Q36353958-D2C5BC1D-6C1A-4E68-826A-4CE129D7F2B3Q36354711-6190C460-EBDA-462F-8470-25957C99CE70Q36357123-7B50E2D2-C38A-4AD0-BD4B-0C5D897D5B76Q36380797-643AFF8E-87DE-4AE0-9F3B-0340A67FF2F2Q36436880-C6CDFFBB-04A6-4173-AD00-CE5A30284FAFQ36548693-674FA801-AD6B-427F-AA62-14A5DFD488F2Q36620321-08B2950C-4C13-4020-BA2E-3C2B3666A33CQ36627744-DABF4DFE-AF6C-409B-9FBA-05FAC4D45314
P2860
Antiviral effects of recombinant tumour necrosis factor in vitro.
description
1986 nî lūn-bûn
@nan
1986年の論文
@ja
1986年学术文章
@wuu
1986年学术文章
@zh
1986年学术文章
@zh-cn
1986年学术文章
@zh-hans
1986年学术文章
@zh-my
1986年学术文章
@zh-sg
1986年學術文章
@yue
1986年學術文章
@zh-hant
name
Antiviral effects of recombinant tumour necrosis factor in vitro.
@en
Antiviral effects of recombinant tumour necrosis factor in vitro.
@nl
type
label
Antiviral effects of recombinant tumour necrosis factor in vitro.
@en
Antiviral effects of recombinant tumour necrosis factor in vitro.
@nl
prefLabel
Antiviral effects of recombinant tumour necrosis factor in vitro.
@en
Antiviral effects of recombinant tumour necrosis factor in vitro.
@nl
P2093
P356
P1433
P1476
Antiviral effects of recombinant tumour necrosis factor in vitro.
@en
P2093
H Jacobsen
H Kirchner
S Mittnacht
P2888
P304
P356
10.1038/323816A0
P407
P577
1986-10-01T00:00:00Z
P6179
1012562820